ANALYSIS OF ALCAT1 INHIBITOR, DAFAGLITAPIN, FOR THE TREATMENT METABOLIC DISEASES

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Shi, Yuguang

Funded by

PERENNA PHARMACEUTICALS, INC.

Research Start Date

10/01/2019

Status

Active

Collaborative Project

Basic Research

Aging

Bioscience Research Panel